RxDoctor Payments Data

David Whitcomb

Gastroenterology · Pittsburgh, PANPI 1386610459

Payments from drug & device makers

$48,995in general payments, 2019–2025

Across 24 payments — averaging $2041.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aimmune Therapeutics, Inc.$26K
  • Nestle Healthcare Nutrition Inc.$10K
  • Samsung Bioepis Co., Ltd.$5K
  • Organon$5K
  • AbbVie$4K
  • Dexcom, Inc.$254
  • plus $161 from 2 others
$2,123in research payments, 2019–2025

Across 1 payment — averaging $2123.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$2K

What the payments were for

  • Consulting fees$28,56159%
  • Speaking & faculty fees$12,42025%
  • Travel & lodging$7,45915%
  • Food & beverage$3011%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Aimmune Therapeutics, Inc.8$25,538
Nestle Healthcare Nutrition Inc.3$9,550
Samsung Bioepis Co., Ltd.2$5,251
Organon2$4,590
AbbVie4$3,652
Dexcom, Inc.3$254
Vivus LLC1$112
Boston Scientific1$49

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,995 in reported general payments places this provider in the 85th percentile of 935 gastroenterology providers in Pennsylvania.

See all gastroenterology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,091
Medicare patients
11
Services billed
13

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →